UM

Browse/Search Results:  1-4 of 4 Help

Selected(0)Clear Items/Page:    Sort:
The Chinese first-episode schizophrenia trial: Background and study design Journal article
Han X., Yuan Y.B., Yu X., Zhao J.P., Wang C.Y., Lu Z., Yang F.D., Dong H., Wu Y.F., Ungvari G.S., Xiang Y.T., Chiu H.F.K.. The Chinese first-episode schizophrenia trial: Background and study design[J]. East Asian Archives of Psychiatry, 2014, 24(4), 169-173.
Authors:  Han X.;  Yuan Y.B.;  Yu X.;  Zhao J.P.;  Wang C.Y.; et al.
Favorite |  | Submit date:2018/12/18
Antipsychotic agents  Clinical trial  Schizophrenia  
An oestrogen-receptor-α-bound human chromatin interactome Journal article
Fullwood M.J., Liu M.H., Pan Y.F., Liu J., Xu H., Mohamed Y.B., Orlov Y.L., Velkov S., Ho A., Mei P.H., Chew E.G.Y., Huang P.Y.H., Welboren W.-J., Han Y., Ooi H.S., Ariyaratne P.N., Vega V.B., Luo Y., Tan P.Y., Choy P.Y., Wansa K.D.S.A., Zhao B., Lim K.S., Leow S.C., Yow J.S., Joseph R., Li H., Desai K.V., Thomsen J.S., Lee Y.K., Karuturi R.K.M., Herve T., Bourque G., Stunnenberg H.G., Ruan X., Cacheux-Rataboul V., Sung W.-K., Liu E.T., Wei C.-L., Cheung E., Ruan Y.. An oestrogen-receptor-α-bound human chromatin interactome[J]. Nature, 2009, 462(7269), 58-64.
Authors:  Fullwood M.J.;  Liu M.H.;  Pan Y.F.;  Liu J.;  Xu H.; et al.
Favorite | TC[WOS]:1283 TC[Scopus]:1363 | Submit date:2018/12/17
Development and validation of an HPLC-DAD method for bis(12)-hupyridone and its application to a pharmacokinetic study Journal article
Yu H., Li W.M., Cheung M.C., Zuo Z., Carlier P.R., Gu Z.M., Chan K., Huang M., Wang Y.T., Han Y.F.. Development and validation of an HPLC-DAD method for bis(12)-hupyridone and its application to a pharmacokinetic study[J]. Journal of Pharmaceutical and Biomedical Analysis, 2009, 49(2), 410.
Authors:  Yu H.;  Li W.M.;  Cheung M.C.;  Zuo Z.;  Carlier P.R.; et al.
Favorite | TC[WOS]:1 TC[Scopus]:2  IF:3.1/3.1 | Submit date:2018/10/31
Alzheimer's Disease  Bis(12)-hupyridone  Hplc-dad  Pharmacokinetics  
Preclinical characterization of intestinal absorption and metabolism of promising anti-Alzheimer's dimer bis(7)-tacrine Journal article
Zhang L., Yu H., Li W.M., Cheung M.C., Pang Y.P., Gu Z.M., Chan K., Wang Y.T., Zuo Z., Han Y.F.. Preclinical characterization of intestinal absorption and metabolism of promising anti-Alzheimer's dimer bis(7)-tacrine[J]. International Journal of Pharmaceutics, 2008, 357(2018-01-02), 85.
Authors:  Zhang L.;  Yu H.;  Li W.M.;  Cheung M.C.;  Pang Y.P.; et al.
Favorite | TC[WOS]:19 TC[Scopus]:20  IF:5.3/5.6 | Submit date:2018/10/31
Bis(7)-tacrine  Intestinal Absorption  Metabolism